These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26742831)

  • 41. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
    Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H
    Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Shorter treatment of pulmonary tuberculosis is only acceptable with at least 4 drugs in the initial combination of tuberculostatic agents].
    Veen J
    Ned Tijdschr Geneeskd; 1996 Nov; 140(44):2164-7. PubMed ID: 8984351
    [No Abstract]   [Full Text] [Related]  

  • 43. Identification of less lipophilic riminophenazine derivatives for the treatment of drug-resistant tuberculosis.
    Zhang D; Lu Y; Liu K; Liu B; Wang J; Zhang G; Zhang H; Liu Y; Wang B; Zheng M; Fu L; Hou Y; Gong N; Lv Y; Li C; Cooper CB; Upton AM; Yin D; Ma Z; Huang H
    J Med Chem; 2012 Oct; 55(19):8409-17. PubMed ID: 22931472
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The resistance status of Mycobacterium tuberculosis in Austria 1992 and 1993].
    Stauffer F; Jaksch G
    Wien Klin Wochenschr; 1995; 107(15):470-1. PubMed ID: 7676686
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3-dioxoindolin-5-yl)semicarbazide derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strain.
    Raja S; Prakash CR
    Arch Pharm Res; 2013 Apr; 36(4):411-22. PubMed ID: 23440582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and biological activities of new hydrazide derivatives.
    Ozdemir A; Turan-Zitouni G; Kaplancikli ZA; Tunali Y
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):825-31. PubMed ID: 18825530
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antitubercular agents. X. The action of derivatives of 3-substituted 2 pyrazinecarboxylic acid].
    Novácek L; Celadník M; Palát K; Kubala E
    Cesk Farm; 1969 Oct; 18(8):385-7. PubMed ID: 4984000
    [No Abstract]   [Full Text] [Related]  

  • 48. Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues.
    Gobis K; Foks H; Serocki M; Augustynowicz-Kopeć E; Napiórkowska A
    Eur J Med Chem; 2015 Jan; 89():13-20. PubMed ID: 25462221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Substituent effects in nitro derivatives of carbazoles investigated by comparison of low-temperature crystallographic studies with density functional theory (DFT) calculations.
    Gajda K; Zarychta B; Kopka K; Daszkiewicz Z; Ejsmont K
    Acta Crystallogr C Struct Chem; 2014 Oct; 70(Pt 10):987-91. PubMed ID: 25279602
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel 4-(morpholin-4-yl)-N'-(arylidene)benzohydrazides: synthesis, antimycobacterial activity and QSAR investigations.
    Raparti V; Chitre T; Bothara K; Kumar V; Dangre S; Khachane C; Gore S; Deshmane B
    Eur J Med Chem; 2009 Oct; 44(10):3954-60. PubMed ID: 19464085
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.
    Martins F; Santos S; Ventura C; Elvas-Leitão R; Santos L; Vitorino S; Reis M; Miranda V; Correia HF; Aires-de-Sousa J; Kovalishyn V; Latino DA; Ramos J; Viveiros M
    Eur J Med Chem; 2014 Jun; 81():119-38. PubMed ID: 24836065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Repurposing the chemical scaffold of the anti-arthritic drug Lobenzarit to target tryptophan biosynthesis in Mycobacterium tuberculosis.
    Evans GL; Gamage SA; Bulloch EM; Baker EN; Denny WA; Lott JS
    Chembiochem; 2014 Apr; 15(6):852-64. PubMed ID: 24623674
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacophore mapping and electronic feature analysis for a series of nitroaromatic compounds with antitubercular activity.
    Tawari NR; Degani MS
    J Comput Chem; 2010 Mar; 31(4):739-51. PubMed ID: 19569203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and anti-mycobacterial evaluation of some pyrazine-2-carboxylic acid hydrazide derivatives.
    Abdel-Aziz M; Abdel-Rahman HM
    Eur J Med Chem; 2010 Aug; 45(8):3384-8. PubMed ID: 20488590
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and antitubercular activity of 2-(substituted phenyl/benzyl-amino)-6-(4-chlorophenyl)-5-(methoxycarbonyl)-4-methyl-3,6-dihydropyrimidin-1-ium chlorides.
    Narayanaswamy VK; Nayak SK; Pillay M; Prasanna R; Coovadia YM; Odhav B
    Chem Biol Drug Des; 2013 Feb; 81(2):219-27. PubMed ID: 23150983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis, biological evaluation and 3D-QSAR study of hydrazide, semicarbazide and thiosemicarbazide derivatives of 4-(adamantan-1-yl)quinoline as anti-tuberculosis agents.
    Patel SR; Gangwal R; Sangamwar AT; Jain R
    Eur J Med Chem; 2014 Oct; 85():255-67. PubMed ID: 25089809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and binary QSAR study of antitubercular quinolylhydrazides.
    Manvar A; Khedkar V; Patel J; Vora V; Dodia N; Patel G; Coutinho E; Shah A
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4896-902. PubMed ID: 23876988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ring-substituted imidazoles as a new class of anti-tuberculosis agents.
    Gupta P; Hameed S; Jain R
    Eur J Med Chem; 2004 Sep; 39(9):805-14. PubMed ID: 15337293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 2,4-Dialkyl-8,9,10,11-tetrahydrobenzo[g]pyrimido[4,5-c]isoquinoline-1,3,7,12(2H,4H)-tetraones as new leads against Mycobacterium tuberculosis.
    Claes P; Cappoen D; Uythethofken C; Jacobs J; Mertens B; Mathys V; Verschaeve L; Huygen K; De Kimpe N
    Eur J Med Chem; 2014 Apr; 77():409-21. PubMed ID: 24681334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent advances in the research of heterocyclic compounds as antitubercular agents.
    Yan M; Ma S
    ChemMedChem; 2012 Dec; 7(12):2063-75. PubMed ID: 23042656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.